Literature DB >> 3337735

Enantiomers of cyclophosphamide and iphosphamide.

P B Farmer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3337735     DOI： 10.1016/0006-2952(88)90767-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  5 in total

1.  Stereoselective pharmacokinetics of ifosfamide in male and female rats.

Authors:  J J Wang; H Lu; K K Chan
Journal:  AAPS PharmSci       Date:  2000

2.  New insights into the pharmacokinetics and metabolism of (R,S)-ifosfamide in cancer patients using a population pharmacokinetic-metabolism model.

Authors:  M P Di Marco; I W Wainer; C L Granvil; G Batist; M P Ducharme
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

3.  Urinary excretion of the enantiomers of ifosfamide and its inactive metabolites in children.

Authors:  J Boos; U Welslau; J Ritter; G Blaschke; G Schellong
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Metabolism and pharmacokinetics of oral and intravenous ifosfamide.

Authors:  V Kurowski; T Cerny; A Küpfer; T Wagner
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

5.  Ifosfamide enantiomers: pharmacokinetics in children.

Authors:  V K Prasad; S A Corlett; K Abaasi; D Heney; I Lewis; H Chrystyn
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.